NEW YORK (GenomeWeb) – Foundation Medicine reported after the close of the market on Monday that its 2015 first quarter revenues rose 68 percent year over year.

The Cambridge, Massachusetts-based cancer genomic analysis firm reported total revenues of $19.3 million for the three months ended March 31, up from $11.5 million in the first quarter of 2014. It fell short of the consensus Wall Street estimate of $21 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.